Stock Information
Lyell Immunopharma Inc (LYEL)
Ticker Symbol: LYEL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $450.04 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -15.4086
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -90.52%
Latest News
-
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Fri, Apr 10, 2026 10:55 AM
-
This WhiteFiber Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Fri, Apr 10, 2026 7:15 AM
-
Needham Initiates Coverage On Lyell Immunopharma with Buy Rating, Announces Price Target of $44
Fri, Apr 10, 2026 6:31 AM
Key Financials
Financial data not available
